Business Wire

Diligent Announces “Diligent One,” the Only Integrated Platform Providing a Unified and Connected GRC Experience

Share

Diligent, a leading GRC SaaS company, today announced Diligent One, a first-of-its-kind platform that provides leadership, boards and practitioners with a single source for all their governance, risk and compliance (GRC) needs. The platform was announced live today at Modern Governance Summit, the world’s premier GRC event, and is available in pilot phase now.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230914836526/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The Diligent One platform. (Graphic: Business Wire)

Over the last six months Diligent has launched board and leadership reporting dashboards for ESG, Audit, Cyber Risk and Investor Engagement to bring clear and consistent insight into organizations’ risk posture. With Diligent One, users have the ability to customize and create dashboards using company data and systems. Combined with Diligent’s best-in-class solutions across governance, risk, compliance, audit and ESG, customers now have a connected view of risk management and the ability to capture and contextualize data and insights and report to the board — all within a single platform.

“In order to see the big picture, you need to start with data. Yet often that data is in spreadsheets or a number of systems accessed by many different applications. This is where risk lives — in the unconnected dots and spaces between siloed systems,” said Brian Stafford, President and CEO of Diligent, during his keynote speech at Modern Governance Summit. “In our conversations with customers over the years, the one constant has been that they are inundated with data and solutions. This is why we are so excited to bring our customers the only platform on the market that provides a single source of truth for all your GRC needs.”

“In today’s fast-moving business environment, obtaining access to high-quality governance data is essential to understanding and meeting the needs of a diverse set of stakeholders,” said Lili Mehta, Senior Vice President and Global Head of Glass Lewis’ Corporate Business. “Board directors and executives now require a unified view of their data so they can more effectively analyze and report to their stakeholders. By delivering meaningful information, companies can proactively manage a wide range of issues and maintain a competitive edge.”

Diligent One is the only platform to deliver automated analyses of virtually any data and provide continuous monitoring of identified areas of risk, allowing organizations to reduce manual work, build actionable insights and expand risk coverage while saving time and money.

“The risk landscape is expanding and evolving at an increasing rate, and understanding the specific risks that could materially impact the business has become more difficult as a result,” said Adam Bailey, SVP and Global Head of Product at Diligent. “A fragmented approach to GRC is no longer sustainable for organizations. An integrated platform is key to providing the insights needed to drive company performance and ensure operational health.”

Learn more about the Diligent One platform here.

About Diligent

Diligent is a leading GRC SaaS company that gives organizations the tools and solutions they need to bring clarity to complex risk, elevate impactful insights and get ahead of a world that is constantly changing. With solutions across governance, risk, compliance, audit and ESG, Diligent empowers more than 1 million users and 700,000 board members and leaders to make better decisions, faster. No matter the challenge. Learn more at diligent.com.

Follow Diligent on LinkedIn, Twitter and Facebook.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For More Information: 
Julia Hanbury 
Senior Communications Manager, Diligent  
+1 (604) 669-4225
Jhanbury@diligent.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Swiss-Based Debiopharm Seeks to Boost Innovation in Japanese Cancer Research Through the New "Ideal Japan” Program18.11.2025 09:00:00 EET | Press release

Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company aiming to cure cancer and infectious diseases, is pleased to announce today the launch of the new IDEAL Japan initiative. This program was initiated to provide financial support to Japanese academic researchers in order to facilitate the transformation of academic innovation into novel therapeutic approaches for combating cancer. IDEAL Japan follows the conclusion of the highly respected JCA (Japanese Cancer Association) Mauvernay Award in Japan, which honored Japanese scientists over the last 20 years, from 2004 through 2024. Debiopharm is now transitioning its historic award into the IDEAL Japan initiative aiming to accelerate preclinical scientific research that could give rise to new treatments for cancer patients. “Our vision is to collaborate to find a cure for cancer,”explained Thierry Mauvernay, President of Debiopharm. “We believe that our ongoing Swiss-Japanese connection needs to evolve and catalyze the trans

Avanzanite Bioscience Secures €32M Series A Investment from MVM Partners18.11.2025 08:00:00 EET | Press release

Avanzanite Bioscience B.V. (Avanzanite), a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced a €32 million Series A growth investment from MVM Partners (MVM), a leading global life-science private equity firm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117345890/en/ Adam Plich, Founder and CEO of Avanzanite. The announcement follows a record-breaking Q3 2025 for Avanzanite, with revenue tripling year-on-year and climbing over 20% quarter-on-quarter. This strategic funding will accelerate the expansion of Avanzanite’s pan-European infrastructure and propel both current and future rare disease product launches. The capital will also enable Avanzanite to form new strategic alliances and acquire assets to expand its portfolio. Avanzanite was built to solve Europe’s rare-disease medicines access gap. Under one pan-European operation, Avanzanite brings toget

Over 30 Million Users Benefit From Ant International’s Bettr Credit Tech Solutions18.11.2025 05:35:00 EET | Press release

Bettr, a leading provider of inclusive financial services and technology business under Ant International, today announced the launch of its proprietary tailored, one-stop credit tech solutions designed to help digital platforms build and scale their lending businesses to better serve micro, small and medium enterprises (MSMEs) in emerging markets. Bettr's credit tech solutions supported over 30 million customers to gain access to credit services through its partners by the end of October 2025, marking a threefold increase compared to the same period in 2024, with MSMEs among the key segments driving this growth. International Finance Corporation estimates a US$8 trillion financing gap for MSMEs in emerging markets and developing economies. With global platforms, from e-commerce to food delivery, entering emerging markets and local platforms in these markets continue to scale, many are looking to offer tailored credit services to better support MSMEs operating on their ecosystems. Doin

Ant International Deepens Participation in Project Ensemble as New Architecture Community Member18.11.2025 05:00:00 EET | Press release

Ant International today announced it has joined Project Ensemble’s Architecture Community to support the design and advancement of Hong Kong’s tokenisation ecosystem. As a Community member, it will be more involved in defining industry standards and supporting the development of Hong Kong’s tokenisation market, together with the Hong Kong Monetary Authority (HKMA) and leading peers. A fintech representative on the Community, Ant International will also contribute its technological and innovation capabilities in tokenisation to support broader industry adoption. This comes at a time when Project Ensemble reaches a new milestone with EnsembleTX, which will see it move from sandbox experiments to live market use within a pilot environment. Through EnsembleTX, Ant International will continue to broaden its partnerships with banks and other committee members, contributing to real-world use cases of tokenisation in real-time global treasury management. It has already supported a successful H

Celltrion Announces European Commission Approval of Additional Line Extension for Omlyclo ™ 300mg18.11.2025 04:51:00 EET | Press release

The European Commission (EC) has granted a line extension in the European Union (EU) for Celltrion’s Omlyclo™ (omalizumab), Europe’s first and only omalizumab biosimilar, for the 300 mg/2ml prefilled syringe (PFS).The European Commission (EC) approved Omlyclo™ 75 mg/0.5ml and 150mg/1ml solution for injection in pre-filled syringe in May 2024. Omlyclo™ is indicated for the treatment of patients with allergic asthma, chronic spontaneous urticaria (CSU) and chronic rhinosinusitis with nasal polyps (CRSwNP). “The additional strength of Omlyclo™ 300mg can significantly decrease the frequency of injections, and reduce injection burden and discomfort, without compromising efficacy and safety,” said Nam Lee, Vice President of Global Medical Affairs at Celltrion. “These improvements may contribute to an enhanced treatment journey for patients by helping reduce the disease burden they face throughout their care. Given its distinctive product profile, Omlyclo™ 300mg has the potential to become an

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye